These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 206576)

  • 41. High grade gliomas.
    Ganz JC
    Prog Brain Res; 2022; 268(1):259-270. PubMed ID: 35074084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P; Lapras C
    Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term survival in malignant glioma. Prognostic factors.
    Phuphanich S; Ferrall S; Greenberg H
    J Fla Med Assoc; 1993 Mar; 80(3):181-4. PubMed ID: 8387566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gliomas in adults.
    Schneider T; Mawrin C; Scherlach C; Skalej M; Firsching R
    Dtsch Arztebl Int; 2010 Nov; 107(45):799-807; quiz 808. PubMed ID: 21124703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
    Suren D; Isiksacan Ozen O
    J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis.
    Annibali D; Whitfield JR; Favuzzi E; Jauset T; Serrano E; Cuartas I; Redondo-Campos S; Folch G; Gonzàlez-Juncà A; Sodir NM; Massó-Vallés D; Beaulieu ME; Swigart LB; Mc Gee MM; Somma MP; Nasi S; Seoane J; Evan GI; Soucek L
    Nat Commun; 2014 Aug; 5():4632. PubMed ID: 25130259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of brain tumors.
    Walker MD
    Med Clin North Am; 1977 Sep; 61(5):1045-51. PubMed ID: 197350
    [No Abstract]   [Full Text] [Related]  

  • 48. [11C-methionine positron emission tomography in brain tumor].
    Kawai N; Kagawa M; Hatakeyama T; Tamiya T; Noshiyama Y; Yamamoto Y; Miki A; Ichikawa T
    No Shinkei Geka; 2008 Oct; 36(10):847-59. PubMed ID: 18975560
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pleomorphic xanthoastrocytomas].
    Lettau M
    Rofo; 2015 Jan; 187(1):3-8. PubMed ID: 25531336
    [No Abstract]   [Full Text] [Related]  

  • 50. [Lymphocytic infiltration in cerebral gliomas].
    Bucciero A; Cerillo A; Quaglietta P; Villano M; Carraturo S; Vizioli L
    Minerva Med; 1992; 83(1-2):25-8. PubMed ID: 1312232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
    Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
    Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.
    Zhu C; Kros JM; van der Weiden M; Zheng P; Cheng C; Mustafa DA
    Acta Neuropathol Commun; 2017 Jan; 5(1):4. PubMed ID: 28073370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The astrocytic nature of glioblastoma demonstrated by tissue culture.
    Escalona-Zapata J; Diez-Nau MD
    Acta Neuropathol; 1981; 53(2):155-60. PubMed ID: 7211205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A grading study of gliomas using computer aided malignancy classification and histologic morphometry.
    Sharma S; Karak AK; Sarkar C; Gomathy G; Banerji AK; Schmitt HP
    J Neurooncol; 1996 Jan; 27(1):75-85. PubMed ID: 8699229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral astrocytic neoplasms in the adult: contribution of histologic examination to the assessment of prognosis.
    Fulling KH; Nelson JS
    Semin Diagn Pathol; 1984 May; 1(2):152-63. PubMed ID: 6100972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of diffuse glioma.
    Esparragosa I; Díez-Valle R; Tejada S; Gállego Pérez-Larraya J
    Presse Med; 2018; 47(11-12 Pt 2):e199-e212. PubMed ID: 30385181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors.
    Zaprianov Z; Christov K
    Cytometry; 1988 Jul; 9(4):380-6. PubMed ID: 2841078
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant cerebellar gliomas. Report of 4 cases with special reference to tissue culture study.
    Escalona-Zapata J; Salinero E; Lacruz C
    J Neurosurg Sci; 1981; 25(2):95-104. PubMed ID: 6278109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.
    Ramachandran RK; Sørensen MD; Aaberg-Jessen C; Hermansen SK; Kristensen BW
    PLoS One; 2017; 12(2):e0172234. PubMed ID: 28234925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.